Clincial Answer: The evidence does not support blue light blocking glasses alone as an effective treatment to prevent or reduce insomnia in adolescents. Small trials show the glasses blunt screen induced melatonin suppression and can modestly advance sleep timing, and the one larger, well conducted 2026 trial that showed a real gain in sleep duration used the glasses only as one piece of a three part program. No adolescent study has isolated the glasses as a standalone intervention and shown it treats diagnosed insomnia.

Strength of Recommendation: C, based on small physiologic trials, one bundled intervention trial, and extrapolation from adult data.

Evidence Used: Van der Lely et al, Journal of Adolescent Health, 2015, studied 13 male teens aged 15 to 17 in a crossover design. Blue light blocking glasses significantly attenuated LED induced melatonin suppression and reduced pre bedtime alertness, but polysomnography scored sleep stages the next night did not change. Maeda-Nishino et al, PLOS ONE, 2025, ran a crossover trial in 39 Japanese boys aged 10 to 12 using partial 40 percent blue blocking lenses worn 3 hours before bed. Bedtime and sleep onset advanced modestly and daytime irritability dropped, but salivary melatonin was unchanged. Wescott et al, JAMA Pediatrics, published online April 20, 2026, ran a registered randomized controlled trial (NCT03806296) at the University of Pittsburgh in 80 habitual night owl high schoolers aged 16 to 19 who normally went to bed at 1 a.m. or later. The 2-week treatment combined a personalized earlier sleep schedule, morning bright light glasses, and evening blue light blocking glasses, and produced an earlier circadian shift and longer weeknight sleep versus a monitoring control. Because the glasses were bundled with schedule changes and morning light therapy, their individual contribution cannot be separated out, and the authors themselves call the results promising but say larger trials are needed before drawing conclusions about sleepiness, academic performance, behavior, or overall wellbeing.

For broader context, Hester et al, Chronobiology International, 2021, reviewed 16 RCTs totaling about 453 mostly adult patients and found reasonable evidence that blue blocking glasses shorten sleep onset latency in sleep disorders, jet lag, and shift work. Janků et al, Chronobiology International, 2020, found that adding the glasses to CBT-I in adults with insomnia improved subjective total sleep time and mood scores versus placebo glasses, with no change in objectively measured sleep duration. The 2023 Cochrane review by Singh et al found conflicting results across small trials and no consistent benefit on sleep quality. Two pediatric sleep hygiene sources, a 2026 Pediatrics technical report and a 2022 PLOS ONE study by Hartley et al, both point to reducing the timing and duration of evening screen use itself as the more consistently supported lever for adolescent sleep, with blue light blocking glasses positioned as an adjunct at best.

Caveats across the whole body of evidence are significant. Adolescent trials are small, often single sex, and use crossover designs vulnerable to carryover effects. None report insomnia specific outcomes like insomnia severity scores or a formal insomnia diagnosis as the primary endpoint. The one trial with a real sleep duration benefit bundled the glasses with other interventions, so the glasses cannot be credited with that effect on their own.

1. Van der Lely S, Frey S, Garbazza C, et al. Blue blocker glasses as a countermeasure for alerting effects of evening light-emitting diode screen exposure in male teenagers. J Adolesc Health. 2015;56(1):113-119.
2. Maeda-Nishino NJ, Yoshimoto R, Ono T, Chiba S, Nishino S. Partial blue light blocking glasses at night advanced sleep phase and reduced daytime irritability, disruptive behavior and improved morning mood, but did not alter salivary melatonin secretion in Japanese male schoolchildren. PLOS ONE. 2025;20(10):e0332877.
3. Wescott DL, Quick AD, Oryshkewych NS, Wallace ML, Beebe D, Buysse DJ, Clark DB, Mirchandaney R, Hasler BP. Chronotherapeutic approaches to target insufficient and late sleep in adolescents: a randomized clinical trial. JAMA Pediatr. 2026 Apr 20:e260976. PMID 42008244.
4. Hester L, Dang D, Barker CJ, et al. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. Chronobiol Int. 2021;38(10):1375-1383.
5. Janků K, Šmotek M, Fárková E, Kopřivová J. Block the light and sleep well: evening blue light filtration as part of cognitive behavioral therapy for insomnia. Chronobiol Int. 2020;37(2):248-259.
6. Singh S, Keller PR, Busija L, et al. Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database Syst Rev. 2023;8:CD013244.
7. Munzer T, Milkovich LM, Madigan S, et al. Digital ecosystems, children, and adolescents: technical report. Pediatrics. 2026;157(2):e2025075321:e2025075321.
8. Hartley S, Royant-Parola S, Zayoud A, Gremy I, Matulonga B. Do both timing and duration of screen use affect sleep patterns in adolescents? PLOS ONE. 2022;17(10):e0276226.